JRCT ID: jRCT1070250064
Registered date:02/09/2025
Implementation and operational evaluation of an "Adverse Drug Reaction Early detection System" at pharmacies
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Patients who have used Littfulo, Torcap, Fruzakura, Omjara, Michiga, or Kelendia. |
| Date of first enrollment | 02/09/2025 |
| Target sample size | 80 |
| Countries of recruitment | |
| Study type | Interventional |
| Intervention(s) | Use of an early adverse drug reaction detection system |
Outcome(s)
| Primary Outcome | Number of adverse drug reactions obtained by this system |
|---|---|
| Secondary Outcome | Number of adverse drug reactions reported to attending physicians, number of unknown adverse drug reactions detected (including trends by age and gender), and satisfaction of insurance pharmacy pharmacists when using this system |
Key inclusion & exclusion criteria
| Age minimum | >= 16age old |
|---|---|
| Age maximum | Not applicable |
| Gender | |
| Include criteria | [Patients] 1. Individuals who bring a prescription containing one of the target drugs, "Litfulo," "Torcap," "Fruzakura," "Omjara," "Michiga," or "Kelendia," to a Sugi Pharmacy or Minaminihon Pharmaceutical Center pharmacy. 2. Individuals aged 16 years or older at the time of consent (regardless of gender). 3. Individuals who have received a full explanation of this study and, after fully understanding it, have given their voluntary written consent. [Pharmacists] 1. All pharmacists working at a Sugi Pharmacy or Minaminihon Pharmaceutical Center pharmacy. 2. Pharmacists who dispense prescriptions to patients who bring a prescription containing one of the target drugs, "Litfulo," "Torcap," "Fruzakura," "Omjara," "Michiga," or "Kelendia." |
| Exclude criteria | [Patients] 1. Those with a history of severe mental illness 2. Those who are mentally and physically unstable and whose physical condition may be adversely affected by participating in this study 3. Those who do not own a smartphone or other communication device and cannot have one provided by the pharmacy 4. Those deemed inappropriate by the pharmacy pharmacist [Pharmacists] *No exclusion criteria will be set. |
Related Information
| Primary Sponsor | Kondo Tomoko |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Tomoko Kondo |
| Address | 8-35-1 Sakuragaoka, Kagoshima City, Kagoshima Kagoshima Japan 890-8544 |
| Telephone | +81-99-275-6279 |
| sktomoko@kufm.kagoshima-u.ac.jp | |
| Affiliation | Kagoshima University |
| Scientific contact | |
| Name | Tomoko Kondo |
| Address | 8-35-1 Sakuragaoka, Kagoshima City, Kagoshima Kagoshima Japan 890-8544 |
| Telephone | +81-99-275-6279 |
| sktomoko@kufm.kagoshima-u.ac.jp | |
| Affiliation | Kagoshima University |